Tighter Restrictions to Derail Indonesia's Economic Rebound? Introduction July 2021 Report

The two main (inter-related) reasons for concern are (1) whether the existing COVID-19 vaccination programs that have been rolled out across the world are enough to end the COVID-19 pandemic, and (2) will governments feel the need to – periodically – impose tighter restrictions in times of rising positive COVID-19 test results in the years ahead, while as a consequence thereof economic activity and social life is allowed to be derailed?

These two concerns have arisen as there are more and more news stories informing that the existing COVID-19 vaccines are not effective enough as anti-bodies seem to wane after some six months. Hence, various countries are now planning to give third doses to certain groups in society (particularly vulnerable people and medical staff). In Indonesia, for now, only medical workers are being targeted for a third COVID-19 shot (although it is safe to assume that – at a later stage – the elderly will be targeted too in Indonesia, simply because they are most vulnerable to a COVID-19 infection).

The big problem is though that if anti-bodies wane, again, some six or twelve months after a third jab, then what? A never-ending cycle of COVID-19 boosters around the globe each year? That not only brings huge logistical challenges and constitutes an expensive program (especially for Indonesia; a huge Archipelago that is home to 270 million people), but we also still do not know the mid and long-term health effects of these relatively new vaccines. Only about a month ago it became known that Pfizer and Moderna vaccines can cause the inflammation of the heart muscle (a side-effect that had not been known when authorities approved these vaccines). Yes, it is a very rare side-effect, but our point here is that if we don’t even fully understand the short-term effects, then how can we be sure about the mid and long-term effects?

We are aware that our view on the COVID-19 vaccination programs is quite different from what the traditional (mainstream) media are reporting, and what governments as well as supranational institutions are saying. We, too, would love to write that the COVID-19 crisis will end soon on the back of safe and effective vaccines. However, the bitter truth is, though, that at this moment there is simply no evidence, or data, that would support this statement. In fact, quite the contrary.

It seems to us that the problem with the ongoing COVID-19 pandemic in relation to vaccines is that the available data are distorted, and therefore multiple interpretable (it then depends on your view or standpoint how you want to interpret these data).

For example, based on reports in mainstream media the majority of hospitalizations and deaths now involve unvaccinated people (although in some countries this trend now seems turning). This easily leads to the conclusion that vaccines protect against COVID-19-related illness and death. However, one can doubt whether this is actually an accurate conclusion because, like with most viruses, natural immunity appears to be stronger (as well as longer-lasting) than a vaccination. And considering there are researchers who claim that asymptomatic COVID-19 infections (essentially meaning that one is not aware he/she had the virus as the infection was not accompanied by any symptoms) can be as high as 81 percent, it can also be claimed that most of the people who are categorized as ‘vaccinated’ are actually being protected by an earlier (unnoticeable) ‘natural’ COVID-19 infection, and not so much by the vaccine (or: it is the combination of a natural infection and the vaccine that brings great immunity). Several researchers are currently looking into this matter (particularly in Israel; the country that was quickest in terms of mass vaccination). However, it seems difficult to deliver hard evidence.

Another example of distorted data involves the seasonal pattern of the COVID-19 virus. Viruses tend to have seasonal patterns (such as influenza that typically hits in winter or the rainy season). The lockdowns around the globe, however, are making it impossible for us to discover such patterns (if such patterns exist at all for COVID-19) as these lockdowns disrupt the natural spread of the virus. While we do certainly understand the need to protect the vulnerable people in society from contracting the COVID-19 virus through lockdowns, it also means that valuable information remains missing (information that would allow policymakers around the globe formulating more effective policies, both for the economy and society).

And so, everyone has to be cautious when formulating any firm conclusions in this ongoing crisis. This is actually the reason why we continue to urge governments and supranational organizations to allow an open and transparent discourse in society, while we urge the mainstream media to undertake investigative journalism instead of simply spreading – and often protecting – governments’ viewpoints (that all seem to draw from the World Health Organization, or WHO, an institution that is certainly not free from political influences or pharmaceutical interests) from critics.

Shutting down discussions on, for example, the possible positive effect of ivermectin on COVID-19-related illness and death (with social media platforms like YouTube, Twitter, and LinkedIn removing such content) is not what made the West great. On the contrary, censorship can limit progress and innovation; the Earth would possibly still be flat and form the center of the universe if we had let censorship determine our worldview. In fact, censorship is actually what is currently feeding suspicion in societies (particularly Western societies as censorship on socio-political matters is a new phenomenon in the West; well, at least for generations alive today). Moreover, when the WHO said the infection fatality rate (or IFR) for COVID-19 was somewhere between 3 and 4 percent around the very beginning of the pandemic (a statement that triggered panic), it turned out to be inaccurate information (‘misinformation’). And yet, the WHO did not see its social media accounts being banned. So, the ‘rules’ do not apply for all.

What we do feel is becoming increasingly clear is that positive COVID-19 test results should not function as sole basis for government policies in the crisis. Again, the data are not complete but various studies do suggest that less than 20 percent of those who test positive for COVID-19 actually show symptoms (which also explains why huge numbers of positive tests don’t translate to huge numbers of hospitalizations or deaths). This means that – by far – the majority of positive COVID-19 test results involve either asymptomatic cases, or the detection of an earlier COVID-19 infection (a piece of dead virus), or false positives. Considering these three groups are highly unlikely to spread COVID-19 to others in society, it would imply that (part of) the government COVID-19-related policies are excessive.

Zooming in on Indonesia

In Indonesia, uncertainty returned to a higher degree in July 2021 as the government decided to impose tighter restrictions at the start of July 2021 (which were extended and relabelled to ‘PPKM Level 1-4’ near the end of the month) in response to record COVID-19 daily case counts (exceeding 50,000 positive test results per day), thereby (possibly) derailing economic growth in the third quarter of the year. One chapter in this report is devoted to the overall current conditions of the Indonesian economy and the (possible) impact of the new restrictions on economic growth in the second half of 2021.

Bali in particular – an island that is dependent on tourism – is in trouble. Earlier, it targeted to re-open to foreign tourists in July or August 2021. However, the recent surge in new COVID-19 cases in Indonesia (as well as on this island) has made the government decide to postpone the plan. This is a major setback for the Balinese as it will take even longer before the recovery can start (although we do doubt whether foreign tourists would flock to Bali under the current circumstances, if restrictions were lifted). In this report, we also zoom in on how the COVID-19 crisis has affected Bali.

Another topic covered in this July 2021 report is the initial public offering (IPO) of local e-commerce giant Bukalapak, one of the country’s unicorns (a startup valued at over USD $1 billion), on the Indonesia Stock Exchange. This is a huge occasion as it is the first Indonesian unicorn tech-startup to become a publicly-listed company in Indonesia. And, more tech-startup IPOs are to follow soon!

One Final Remark

We want to conclude this edition’s introduction by returning to the West, or more precisely, the United States. While the world economy remains struggling due to the COVID-19 restrictions – with countries such as Indonesia more-or-less in lockdown mode – we witnessed live coverage of billionaires Richard Branson and Jeff Bezos undertaking a short joy-ride into space.

It brings an awkward situation: while hundreds of millions of people (if not more) around the globe face travel restrictions and/or are under heavy financial stress due to COVID-19-related restrictions, a couple of billionaires can visit space.

Moreover, the ruling powers in the West (governments, supranational organizations and media) are currently pushing through massive climate change policies that are supported by people like Bezos and Branson (who both pledged huge amounts of money to curtail global warming). And yet, these guys are now poking holes in the ozone layer (which could lead to permanent damage if done frequently), just for fun!

Richard van der Schaar
Managing Director Indonesia Investments
2 August 2021, Yogyakarta (Indonesia)

This is the introduction to the July 2021 report of Indonesia Investments that was released on 5 August 2021.

Take a glance inside the report here!

The July 2021 report can be ordered by sending an email to [email protected] or a message to +62.882.9875.1125 (including WhatsApp).

Price of this (electronic) report:

Rp 150,000
USD $10,-
EUR €10,-

.

‹ Kembali ke Kolom Berita

Bahas

Silakan login atau berlangganan untuk mengomentari kolom ini